GENITOURINARY CANCER I
DATE: 13-11-2024
TIME: 16:30 / 18:00
DURATION: 1 hour and 30 minutos
LOCATION: Plenary Room
THERAPEUTIC SEQUENCING IN CASTRATION-RESISTANT PROSTATE CANCER IN THE ERA OF TRIPLE THERAPY AS THE 1ST APPROACH IN HORMONE SENSITIVITY
ROLE OF RADIOPHARMACEUTICALS IN THE TREATMENT OF MCRPC
INTENSIFICATION OF SYSTEMIC TREATMENT IN BIOCHEMICAL RECURRENCE IN HOMONOSENSITIVE HIGH-RISK PROSTATE CARCINOMA: CLINICALLY SIGNIFICANT?